|
GEMIN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.471630E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.117500E-02 |
| Normal-vs-Stage2 |
3.305800E-02 |
| Normal-vs-Stage3 |
4.186600E-01 |
| Normal-vs-Stage4 |
9.803400E-01 |
| Stage1-vs-Stage2 |
4.111800E-01 |
| Stage1-vs-Stage3 |
1.105640E-01 |
| Stage1-vs-Stage4 |
4.197200E-01 |
| Stage2-vs-Stage3 |
4.992500E-02 |
| Stage2-vs-Stage4 |
2.369600E-01 |
| Stage3-vs-Stage4 |
6.562200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.739840E-01 |
| Normal-vs-AfricanAmerican |
2.727600E-02 |
| Normal-vs-Asian |
9.698600E-01 |
| Caucasian-vs-AfricanAmerican |
2.717800E-01 |
| Caucasian-vs-Asian |
6.942800E-01 |
| AfricanAmerican-vs-Asian |
6.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.602220E-02 |
| Normal-vs-Female |
3.371800E-01 |
| Male-vs-Female |
7.936600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.032420E-01 |
| Normal-vs-Extreme_Weight |
5.637400E-03 |
| Normal-vs-Obese |
9.418200E-01 |
| Normal-vs-Extreme_Obese |
5.264200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.069600E-01 |
| Normal_Weight-vs-Obese |
1.806760E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.718800E-01 |
| Extreme_Weight-vs-Obese |
4.425600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.732400E-01 |
| Obese-vs-Extreme_Obese |
5.431600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.179980E-01 |
| Normal-vs-Age(41-60Yrs) |
6.032000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.154200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.121650E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.158000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.609900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.441600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.810000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.164200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.141800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.957500E-02 |
| Normal-VS-Type2 PRCC |
3.347700E-02 |
| Normal-VS-KIRP CIMP |
3.624000E-02 |
| Normal-VS-Unclassified PRCC |
7.352800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.080400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.026200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.814800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.598130E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.090400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.146000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.683900E-03 |
| Normal-vs-N1 |
6.215700E-02 |
| Normal-vs-N2 |
2.737800E-02 |
| N0-vs-N1 |
4.403700E-03 |
| N0-vs-N2 |
7.992400E-01 |
| N1-vs-N2 |
5.455300E-03 |
|
|
